NCT00187278已完成不适用
Biventricular Pacing for Atrioventricular Block in Left Ventricular Dysfunction to Prevent Cardiac Desynchronization
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,833
- 试验地点
- 2
- 主要终点
- Death or Heart Failure Hospitalization
研究概览
简要总结
The primary purpose of the study is to evaluate if patients with a standard indication for permanent ventricular pacing, left ventricular ejection fraction without limit, or any QRS duration will profit from the prevention of ventricular desynchronisation.
详细描述
The study will be performed as a controlled, single-blind, international, multicenter, prospective, randomized, parallel group design.
In order to pragmatically examine the effectiveness of biventricular pacing in patients with an indication for ventricular pacing, the study group with biventricular pacing is compared to a control group with standard pacemakers which only allow univentricular (right ventricular) stimulation, as it has been the standard outside of clinical studies until so far.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Presence of an indication for ventricular pacing according to the actual guidelines for the implantation of cardiac pacemakers and a need for frequent (or even permanent) ventricular pacing for:
- •Permanent 3rd degree atrioventricular (AV)-block or
- •Intermittent 3rd degree AV-block in combination with 1st degree AV-block with a pQ-interval ≥ 220 ms or
- •2nd degree AV-block type Mobitz II in combination with 1st degree AV-block with a pQ-interval ≥ 220 ms or
- •2nd degree AV-block type Mobitz I (if indicated) in combination with 1st degree AV-block with a pQ-interval ≥ 220 ms or
- •1st degree AV-block with a pQ-interval ≥ 220 ms and indication for ventricular pacing (includes indication for ventricular pacing based on long HV interval measured during invasive electrophysiological testing) or
- •Sick-sinus-syndrome with symptomatic sinus bradycardia or sinus arrest as primary indication for device implantation in combination with long 1st degree AV-block with a pQ-interval ≥ 220 ms or
- •Chronic (permanent) atrial fibrillation (flutter or tachycardia) with a spontaneous heart (ventricular) rate at rest ≤ 60/min or
- •Chronic (permanent) atrial fibrillation (flutter or tachycardia) with a spontaneous heart (ventricular) rate at rest ≤ 75/min, if initiation or increase of pharmacological treatment with a relevant heart rate lowering effect (negative chronotropic effect) is planned for the time after pacemaker implantation (i.e. ß-blockers for heart failure and rate control)
- •Patients scheduled for AV node ablation
- •Any QRS duration and morphology
- •Left ventricular ejection fraction (LVEF) without limit as measured by echocardiography (in at least one plane, either 4- or 2-chamber or apical long axis view)
- •Signed written informed consent of the patient or a first-degree relative for study participation after informing the patient/relative about the risks and the aim of the study
- •Willingness and ability to comply with the prescribed follow-up tests and schedule of evaluations.
- •Absence of an implanted ventricular pacing device (patients with atrial pacemakers and new need for ventricular pacing may be included)
排除标准
- •Implanted Cardioverter Defibrillator or consideration for implantation of an ICD due to arrhythmia indication. However, ICD implant for primary prevention of sudden cardiac death in patients with LVEF ≤ 35 % (in accordance with the actual guidelines for the implantation of arrhythmia devices[LVEF < 30%] and in accordance with the results of the SCD-Heft study [LVEF < 35%) will be allowed.
- •Implanted ventricular pacing device
- •Status 1 for cardiac transplantation and likelihood to receive transplantation within 2 years (these patients would not be expected to fulfill the follow-up requirements as outlined in this protocol)
- •Evidence of acute left ventricular dysfunction and high probability for its reversibility (e.g. acute myocarditis, tachycardiomyopathy)
- •Implanted prosthetic tricuspid valve
- •Severe musculoskeletal disorder(s)
- •Age below 18 years
- •Current or planned pregnancy in the next 6 months
- •Current or recent (within the past 30 days) participation in any other clinical investigation
- •Life expectancy of less than 6 months
- •Patient's inability to independently comprehend and complete the Quality of Life (QoL) questionnaire
结局指标
主要结局
Death or Heart Failure Hospitalization
时间窗: Study duration (5.7 years mean follow-up)
Number of subjects who experienced death or hospitalization where heart failure is a primary cause of hospitalization
Total Mortality
时间窗: Study duration (5.7 years mean follow-up)
Number of deaths observed
次要结局
- Health Related Quality of Life Measured by the Minnesota Living With Heart Failure Questionnaire©(24 months post-implant)
- Chronic Atrial Fibrillation (Defined as Presence of Atrial Fibrillation in Two Subsequent ECG´s/Visits)(Study duration (5.7 years mean follow-up))
- Incidence of Hospitalizations for Deterioration of Heart Failure(Study duration (5.7 years mean follow-up))
- Duration of Hospitalizations for Cardiovascular Events(Study Duration (5.7 years mean follow-up))
- Adverse Events Related to Left Ventricular Lead(Study Duration (5.7 years mean follow-up))
- Cardiac Structure and Function(12 & 24 months)
- Functional Capacity as Measured by the Distance Covered in the 6-minute Walk Test(24 months post-implant)
- Incidence of Hospitalizations for Any Reason(Study duration (5.7 years mean follow-up))
- Successful Implantation of the Left Ventricular Lead(Implantation)
- Duration of Hospitalizations for Deterioration of Heart Failure(Study Duration (5.7 years mean follow-up))
- Death Due to Cardiovascular Causes(Study duration (5.7 years mean follow-up))
- Incidence of Hospitalizations for Cardiovascular Events(Study duration (5.7 years mean follow-up))
- Duration of Hospitalizations for Any Reason(Study duration (5.7 years mean follow-up))
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT StudyFirst Degree Atrioventricular BlockNCT02150538Gianluca Botto164
终止
不适用
Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and PaceAtrial FibrillationCongestive Heart FailureNCT00356057Biotronik, Inc.153
终止
不适用
Biventricular Pacing After Cardiopulmonary BypassHeart FailureNCT00498940Henry M. Spotnitz111
已完成
不适用
Choosing the Right Pacing Mode in Heart Failure - The CHOICE TrialHeart FailureNCT00875732University of Dundee22
已完成
1 期
A Study to Determine the Effect of Bi-Ventricular Pacing on Cardiac Hemodynamics After Coronary Artery Bypass GraftCoronary DiseaseNCT00316368Unity Health Toronto60